Article thumbnail
Location of Repository

Identification and Characterization of HTLV-1 HBZ Post-Translational Modifications

By Nathan Dissinger, Nikolozi Shkriabai, Sonja Hess, Jacob Al-Saleem, Mamuka Kvaratskhelia and Patrick L. Green


Human T-cell leukemia virus type-1 (HTLV-1) is estimated to infect 15–25 million people worldwide, with several areas including southern Japan and the Caribbean basin being endemic. The virus is the etiological agent of debilitating and fatal diseases, for which there is currently no long-term cure. In the majority of cases of leukemia caused by HTLV-1, only a single viral gene, hbz, and its cognate protein, HBZ, are expressed and their importance is increasingly being recognized in the development of HTLV-1-associated disease. We hypothesized that HBZ, like other HTLV-1 proteins, has properties and functions regulated by post-translational modifications (PTMs) that affect specific signaling pathways important for disease development. To date, PTM of HBZ has not been described. We used an affinity-tagged protein and mass spectrometry method to identify seven modifications of HBZ for the first time. We examined how these PTMs affected the ability of HBZ to modulate several pathways, as measured using luciferase reporter assays. Herein, we report that none of the identified PTMs affected HBZ stability or its regulation of tested pathways

Publisher: Public Library of Science
Year: 2014
OAI identifier:
Provided by: Caltech Authors

Suggested articles

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.